This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Of the 75% of physicians who preferred in-person visits from Medtech representatives prior to Covid-19, 47% now prefer virtual exchanges or less-frequent visits. Furthermore, only 10% of physicians had met with a pharmaceutical company representative in a hospital. no pharmaceutical reps). Respondents had an average of 1.5
Without this information, providers cant ensure the safety or efficacy of the medications they prescribe. Lacking this fundamental understanding as a salesrep can negatively impact a providers interest in a new product and their business relationship with the company. [1]
As pharmareps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks.
Mark Bard: I think the most challenging aspect of the current situation is the inability of anyone – patient, physician, payor, or pharma – to truly predict how long it will take for various parts of the system to get to what becomes the steady state – a new way of operating, the new normal. How does the situation impact pharma?
companies are paying reps 50-75% over market rates. With conflicting stats like these, its no wonder theres an identity crisis in the sales force. 3 It turns out, the best salesreps do things that technology cant dojust like Captain Sully did. That information would be hard to find elsewhere, an HCP said.
A decade ago, pharmareps could easily book in-person meetings with doctors, build lasting relationships, and crush their sales quotas. Physicians are harder to get hold of in 2023. We have yet to talk about the increased level of competition that modern reps have to deal with. These days? Things are complicated.
The healthcare industry is no exception, and for pharmasalesreps engaging with healthcare professionals, human connection is key. But today, communication between your reps and HCPs may be limited, or even embargoed altogether. Visit www.storyvine.com for more information.
With much competition between drug companies and decreased time for doctors to meet with pharmasalesreps, there has been a call for reinventing commonplace marketing strategies. physicians through doctor-specific codes and in-house facility logins. The technology identifies.
Challenge 1: Limited set of marketing and sales tools. Pharma has always been highly restrictive in terms of the different tools you can use to engage, educate and inform about prescription medicines. This high-stakes, low-frequency environment makes it imperative to ensure every sales and marketing action count.
The healthcare industry is no exception, and for pharmasalesreps engaging with healthcare professionals, human connection is key. But today, communication between your reps and HCPs may be limited, or even embargoed altogether. Visit www.storyvine.com for more information.
Once you know how they’re using the technology to empower their salesreps, it’s easy to see why companies are reporting sales performance increases of more than 20%. That’s a lot of information. Most find it increasingly difficult to arrange one-on-one meetings with prescribing physicians.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content